Statins: link to osteoporosis depends on dosage

A new study has found that the link between statin risk and osteoporosis varies greatly with medication dosage.

(Catharine Paddock/ Medical News Today) — New research suggests that there is a relationship between statin use and the chances of receiving a diagnosis of osteoporosis, a condition that weakens bones. It also proposes that the nature of the relationship depends on the dose of the cholesterol lowering drug.

The Annals of the Rheumatic Diseases study investigated nearly the whole of the population of Austria.

Altogether, the researchers analyzed health data from the start of 2006 to the end of 2007 on 7.9 million people.

They compared rates of osteoporosis diagnosis in statin users with those who had never used statins. They looked at the effect of different doses of lovastatin, pravastatin, rosuvastatin, and simvastatin. (…)

read full story

share/partager